Literature DB >> 11884610

Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4.

Xiaohong Leng1, Martin Noble, Peter D Adams, Jun Qin, J Wade Harper.   

Abstract

p107 functions to control cell division and development through interaction with members of the E2F family of transcription factors. p107 is phosphorylated in a cell cycle-regulated manner, and its phosphorylation leads to its release from E2F. Although it is known that p107 physically associates with E- and A-type cyclin/cyclin-dependent kinase 2 (Cdk2) complexes through a cyclin-binding RXL motif located in the spacer domain, the mechanisms underlying p107 inactivation via phosphorylation remain poorly defined. Recent genetic evidence indicates a requirement for cyclin D1/Cdk4 complexes in p107 inactivation. In this work, we provide direct biochemical evidence for the involvement of cyclin D1/Cdk4 in the inactivation of p107's growth-suppressive function. While coexpression of cyclin D1/Cdk4 can reverse the cell cycle arrest properties of p107 in Saos-2 cells, we find that p107 in which the Lys-Arg-Arg-Leu sequence of the RXL motif is replaced by four alanine residues is largely refractory to inactivation by cyclin D/Cdk4, indicating a role for this motif in p107 inactivation without a requirement for its tight interaction with cyclin D1/Cdk4. We identified four phosphorylation sites in p107 (Thr-369, Ser-640, Ser-964, and Ser-975) that are efficiently phosphorylated by Cdk4 but not by Cdk2 in vitro and are also phosphorylated in tissue culture cells. Growth suppression by p107 containing nonphosphorylatable residues in these four sites is not reversed by coexpression of cyclin D1/Cdk4. In model p107 spacer region peptides, phosphorylation of S640 by cyclin D1/Cdk4 is strictly dependent upon an intact RXL motif, but phosphorylation of this site in the absence of an RXL motif can be partially restored by replacement of S643 by arginine. This suggests that one role for the RXL motif is to facilitate phosphorylation of nonconsensus Cdk substrates. Taken together, these data indicate that p107 is inactivated by cyclin D1/Cdk4 via direct phosphorylation and that the RXL motif of p107 plays a role in its inactivation by Cdk4 in the absence of stable binding.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884610      PMCID: PMC133692          DOI: 10.1128/MCB.22.7.2242-2254.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  68 in total

1.  Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization.

Authors:  J Sage; G J Mulligan; L D Attardi; A Miller; S Chen; B Williams; E Theodorou; T Jacks
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

2.  Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions.

Authors:  J H Dannenberg; A van Rossum; L Schuijff; H te Riele
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

3.  Requirements for cell cycle arrest by p16INK4a.

Authors:  J L Bruce; R K Hurford; M Classon; J Koh; N Dyson
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

4.  Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication.

Authors:  T Ma; N Zou; B Y Lin; L T Chow; J W Harper
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

5.  Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes.

Authors:  P D Adams; X Li; W R Sellers; K B Baker; X Leng; J W Harper; Y Taya; W G Kaelin
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

6.  Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block.

Authors:  K Hansen; T Farkas; J Lukas; K Holm; L Rönnstrand; J Bartek
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

7.  The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.

Authors:  N R Brown; M E Noble; J A Endicott; L N Johnson
Journal:  Nat Cell Biol       Date:  1999-11       Impact factor: 28.824

8.  E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control.

Authors:  S Gaubatz; G J Lindeman; S Ishida; L Jakoi; J R Nevins; D M Livingston; R E Rempel
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

9.  Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.

Authors:  B A Schulman; D L Lindstrom; E Harlow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.

Authors:  B O Petersen; J Lukas; C S Sørensen; J Bartek; K Helin
Journal:  EMBO J       Date:  1999-01-15       Impact factor: 11.598

View more
  37 in total

1.  Crystal structure of human CDK4 in complex with a D-type cyclin.

Authors:  Philip J Day; Anne Cleasby; Ian J Tickle; Marc O'Reilly; Joe E Coyle; Finn P Holding; Rachel L McMenamin; Jeff Yon; Rajiv Chopra; Christoph Lengauer; Harren Jhoti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

2.  Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation.

Authors:  I D Tonks; P Mukhopadhyay; W A Schroder; A Sorolla; A W Mould; H Y Handoko; B Ferguson; H K Muller; P Keith; N K Hayward; G J Walker; G F Kay
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

3.  Genotoxic stress-induced cyclin D1 phosphorylation and proteolysis are required for genomic stability.

Authors:  Laura L Pontano; Priya Aggarwal; Olena Barbash; Eric J Brown; Craig H Bassing; J Alan Diehl
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

Review 4.  Regulation of the human catalytic subunit of telomerase (hTERT).

Authors:  Michael Daniel; Gregory W Peek; Trygve O Tollefsbol
Journal:  Gene       Date:  2012-02-13       Impact factor: 3.688

5.  Combined effect of cyclin D3 expression and abrogation of cyclin D1 prevent mouse skin tumor development.

Authors:  Xian Wang; Christopher Sistrunk; Paula L Miliani de Marval; Yongbaek Kim; Marcelo L Rodriguez-Puebla
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

6.  Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene.

Authors:  Gregory W Peek; Trygve O Tollefsbol
Journal:  Exp Cell Res       Date:  2016-03-23       Impact factor: 3.905

7.  The structure of CDK4/cyclin D3 has implications for models of CDK activation.

Authors:  T Takaki; A Echalier; N R Brown; T Hunt; J A Endicott; M E M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

8.  Perspectives in cell cycle regulation: lessons from an anoxic vertebrate.

Authors:  Kyle K Biggar; Kenneth B Storey
Journal:  Curr Genomics       Date:  2009-12       Impact factor: 2.236

9.  Oxidative status of muscle is determined by p107 regulation of PGC-1alpha.

Authors:  Anthony Scimè; Vahab D Soleimani; C Florian Bentzinger; Mark A Gillespie; Fabien Le Grand; Guillaume Grenier; Lisa Bevilacqua; Mary-Ellen Harper; Michael A Rudnicki
Journal:  J Cell Biol       Date:  2010-08-16       Impact factor: 10.539

10.  Deletion of the p107/p130-binding domain of Mip130/LIN-9 bypasses the requirement for CDK4 activity for the dissociation of Mip130/LIN-9 from p107/p130-E2F4 complex.

Authors:  Raudel Sandoval; Mark Pilkinton; Oscar R Colamonici
Journal:  Exp Cell Res       Date:  2009-07-18       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.